Trials / Unknown
UnknownNCT01368419
Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
Phase II Study of Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is to explore the clinical efficacy of continuous Endostar infusion combined with radiotherapy in esophageal cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Endostar | 75mg Endostar in 235mL normal saline, 24h continuous infusion, 6 weeks |
| RADIATION | Radiotherapy | 6～15MV X-ray, 2Gy/time，5times/week，6 weeks |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2011-06-08
- Last updated
- 2013-04-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01368419. Inclusion in this directory is not an endorsement.